These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 3019574)
21. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. Teshigawara K; Maeda M; Nishino K; Nikaido T; Uchiyama T; Tsudo M; Wano Y; Yodoi J J Mol Cell Immunol; 1985; 2(1):17-26. PubMed ID: 2978223 [TBL] [Abstract][Full Text] [Related]
22. Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function. Muraguchi A; Kehrl JH; Longo DL; Volkman DJ; Smith KA; Fauci AS J Exp Med; 1985 Jan; 161(1):181-97. PubMed ID: 2981952 [TBL] [Abstract][Full Text] [Related]
23. Rat lymphoid cell lines producing human T cell leukemia virus. II. Constitutive expression of rat interleukin 2 receptor. Yodoi J; Okada M; Tagaya Y; Teshigawara K; Fukui K; Ishida N; Ikuta K; Maeda M; Honjo T; Osawa H J Exp Med; 1985 May; 161(5):924-34. PubMed ID: 2985731 [TBL] [Abstract][Full Text] [Related]
24. Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide termed T27 with the 55-kDa Tac peptide. Szöllösi J; Damjanovich S; Goldman CK; Fulwyler MJ; Aszalos AA; Goldstein G; Rao P; Talle MA; Waldmann TA Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7246-50. PubMed ID: 2444977 [TBL] [Abstract][Full Text] [Related]
25. The role of the multichain IL-2 receptor complex in the control of normal and malignant T-cell proliferation. Waldmann TA Environ Health Perspect; 1987 Nov; 75():11-5. PubMed ID: 2891501 [TBL] [Abstract][Full Text] [Related]
26. Differential effects on expression of IL-2 receptors (p55 and p70) by the HTLV-I pX DNA. Sabe H; Tanaka A; Siomi H; Koyasu S; Yonehara S; Yahara I; Tagaya Y; Sugie K; Teshigawara K; Yodoi J Int J Cancer; 1988 Jun; 41(6):880-5. PubMed ID: 2897342 [TBL] [Abstract][Full Text] [Related]
27. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Sugamura K; Fujii M; Kannagi M; Sakitani M; Takeuchi M; Hinuma Y Int J Cancer; 1984 Aug; 34(2):221-8. PubMed ID: 6088403 [TBL] [Abstract][Full Text] [Related]
28. The expression of the p75 subunit of interleukin 2 receptor in Tac negative leukemic cells of two patients with large granular lymphocytic leukemia. Tagawa S; Hatakeyama M; Shibano M; Taniguchi T; Kitani T Blood; 1988 Apr; 71(4):1161-4. PubMed ID: 2833327 [TBL] [Abstract][Full Text] [Related]
29. Dissociation of interleukin-2-mediated cell proliferation and interleukin-2 receptor upregulation in adult T-cell leukemia cells. Hori T; Uchiyama T; Umadome H; Tamori S; Tsudo M; Araki K; Uchino H Leuk Res; 1986; 10(12):1447-53. PubMed ID: 2879074 [TBL] [Abstract][Full Text] [Related]
30. A new monoclonal antibody recognizing an antigen of human lymphocytes similar or identical to Tac antigen. Tanaka Y; Tozawa H; Koyanagi Y; Yamamoto N; Hinuma Y Microbiol Immunol; 1984; 28(9):1041-55. PubMed ID: 6083438 [TBL] [Abstract][Full Text] [Related]
31. Tac-positive, HTLV-negative, T helper phenotype chronic lymphocytic leukemia cells. Pandolfi F; De Rossi G; Ranucci A; Bonomo G; Pasqualetti D; Napolitano M; Manzari V Blood; 1985 Jun; 65(6):1531-7. PubMed ID: 2986747 [TBL] [Abstract][Full Text] [Related]
32. IL-2 receptor expression in the haematologic malignancies: a target for immunotherapy. Waldmann TA Cancer Surv; 1989; 8(4):891-903. PubMed ID: 2701734 [TBL] [Abstract][Full Text] [Related]
33. Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T cell leukemia. Maeda M; Arima N; Daitoku Y; Kashihara M; Okamoto H; Uchiyama T; Shirono K; Matsuoka M; Hattori T; Takatsuki K Blood; 1987 Nov; 70(5):1407-11. PubMed ID: 2889484 [TBL] [Abstract][Full Text] [Related]
34. Anti-IL-2 receptor monoclonal antibody (anti-Tac) treatment of T-cell lymphoma. Waldmann TA Important Adv Oncol; 1994; ():131-41. PubMed ID: 8206486 [TBL] [Abstract][Full Text] [Related]
35. The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-I-associated disorders. Waldmann TA J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S179-85. PubMed ID: 8797721 [TBL] [Abstract][Full Text] [Related]
37. Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferation. Tomita S; Ambrus JL; Volkman DJ; Longo DL; Mitsuya H; Reitz MS; Fauci AS J Exp Med; 1985 Jul; 162(1):393-8. PubMed ID: 2989412 [TBL] [Abstract][Full Text] [Related]
38. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells. Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419 [TBL] [Abstract][Full Text] [Related]
39. Characterization of human interleukin 2 receptor (Tac antigen) in normal and leukemic T cells: co-expression of normal and aberrant receptors on Hut-102 cells. Wano Y; Uchiyama T; Fukui K; Maeda M; Uchino H; Yodoi J J Immunol; 1984 Jun; 132(6):3005-10. PubMed ID: 6327813 [TBL] [Abstract][Full Text] [Related]
40. Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen. Robb RJ; Greene WC; Rusk CM J Exp Med; 1984 Oct; 160(4):1126-46. PubMed ID: 6090574 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]